Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.

J A S Crippa, J E C Hallak, J P Machado-de-Sousa, R H C Queiroz, M Bergamaschi et al.

Case Report Journal of clinical pharmacy and therapeutics 2013

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D23095052'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Abstract

WHAT IS KNOWN AND OBJECTIVE: Cannabis withdrawal in heavy users is commonly followed by increased anxiety, insomnia, loss of appetite, migraine, irritability, restlessness and other physical and psychological signs. Tolerance to cannabis and cannabis withdrawal symptoms are believed to be the result of the desensitization of CB1 receptors by THC. CASE SUMMARY: This report describes the case of a 19-year-old woman with cannabis withdrawal syndrome treated with cannabidiol (CBD) for 10 days. Daily symptom assessments demonstrated the absence of significant withdrawal, anxiety and dissociative symptoms during the treatment. WHAT IS NEW AND CONCLUSION: CBD can be effective for the treatment of cannabis withdrawal syndrome.

Used In Evidence Reviews

A CBD（大麻二酚）用于失眠

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.

Embed This Widget

Abstract

Used In Evidence Reviews

Similar Papers

Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials.

Cannabidiol in humans-the quest for therapeutic targets.

NUTRITIONAL AND TOXICOLOGICAL ASPECTS OF SPIRULINA (ARTHROSPIRA).

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.

Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.